Table 4.

In-hospital, 30 days, and 6 and 12 months of follow-up and cumulative adverse cardiac events at 376 ± 18.1 days.

Variable (n = 201)	N (%)
	In-hospital and 30 days	6 months	12 months	Cumulative
Any cause of death	1 (0.5)	2 (1.0)	2 (1.0)	5 (2.5)
Cardiovascular death	1 (0.5)	2 (1.0)	0 (0.0)	3 (1.5)
Acute myocardial infarction (MI)	1 (0.5)	1 (0.5)	0 (0.0)	2 (1.0)
Cerebrovascular accident (CVA)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Death/MI/CVA	1 (0.5)	3 (1.5)	2 (1.0)	6 (3.0)
Target lesion revascularization (TLR)	2 (1.0)	6 (3.0)	9 (4.5)	17 (8.5)
Unplanned revascularization	2 (1.0)	8 (4.0)	9 (4.5)	19 (9.5)
MACE (cardiovascular death, MI, TLR)	3 (1.5)	9 (4.5)	9 (4.5)	21 (10.5)
Stent thrombosis (definitive, probable)	1 (0.5)	0 (0.0)	0 (0.0)	1 (0.5)

Abbreviations: MACE, major adverse cardiac events.